Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis
- PMID: 25213342
- PMCID: PMC4213289
- DOI: 10.1161/STROKEAHA.114.005669
Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis
Abstract
Background and purpose: Carotid artery intima-media thickness (IMT) and plaque are noninvasive markers of subclinical arterial injury that predict incident cardiovascular disease. We evaluated predictors of longitudinal changes in IMT and new plaque during a decade in a longitudinal multiethnic cohort.
Methods: Carotid IMT and plaque were evaluated in Multi-Ethnic Study of Atherosclerosis (MESA) participants at exams 1 and 5, a mean (standard deviation) of 9.4 (0.5) years later. Far wall carotid IMT was measured in both common and internal carotid arteries. A plaque score was calculated from all carotid segments. Mixed-effects longitudinal and multivariate regression models evaluated associations of baseline risk factors and time-updated medication use with IMT progression and plaque formation.
Results: The 3441 MESA participants were aged 60.3 (9.4) years (53% women; 26% blacks, 22% Hispanic, 13% Chinese); 1620 (47%) had carotid plaque. Mean common carotid artery IMT progression was 11.8 (12.8) μm/year, and 1923 (56%) subjects developed new plaque. IMT progressed more slowly in Chinese (β=-2.89; P=0.001) and Hispanic participants (β=-1.81; P=0.02), and with higher baseline high-density lipoprotein cholesterol (per 5 mg/dL; β=-0.22; P=0.03), antihypertensive use (β=-2.06; P=0.0004), and time on antihypertensive medications (years; β=-0.29; P<0.0001). Traditional risk factors were associated with new plaque formation, with strong associations for cigarette use (odds ratio, 2.31; P<0.0001) and protection by black ethnicity (odds ratio, 0.68; P<0.0001).
Conclusions: In a large, multiethnic cohort with a decade of follow-up, ethnicity was a strong, independent predictor of carotid IMT and plaque progression. Antihypertensive medication use was associated with less subclinical disease progression.
Keywords: atherosclerosis; carotid arteries; epidemiology; risk factors.
© 2014 American Heart Association, Inc.
Figures

Similar articles
-
Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis.Stroke. 2011 Nov;42(11):3017-21. doi: 10.1161/STROKEAHA.111.625186. Epub 2011 Sep 1. Stroke. 2011. PMID: 21885840 Free PMC article.
-
Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.Stroke. 2012 Jul;43(7):1818-23. doi: 10.1161/STROKEAHA.111.646596. Epub 2012 May 1. Stroke. 2012. PMID: 22550052 Clinical Trial.
-
25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis.Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2639-45. doi: 10.1161/ATVBAHA.113.301781. Epub 2013 Jun 27. Arterioscler Thromb Vasc Biol. 2013. PMID: 23814117 Free PMC article.
-
Carotid Intima-Media Thickness as Surrogate for and Predictor of CVD.Glob Heart. 2016 Sep;11(3):295-312.e3. doi: 10.1016/j.gheart.2016.08.006. Glob Heart. 2016. PMID: 27741977 Review.
-
Providing Evidence for Subclinical CVD in Risk Assessment.Glob Heart. 2016 Sep;11(3):275-285. doi: 10.1016/j.gheart.2016.08.003. Glob Heart. 2016. PMID: 27741975 Free PMC article. Review.
Cited by
-
Predictors for carotid and femoral artery intima-media thickness in a non-diabetic sleep clinic cohort.PLoS One. 2021 Jun 4;16(6):e0252569. doi: 10.1371/journal.pone.0252569. eCollection 2021. PLoS One. 2021. PMID: 34086802 Free PMC article. Clinical Trial.
-
Association of Blood Copper With the Subclinical Carotid Atherosclerosis: An Observational Study.J Am Heart Assoc. 2024 May 7;13(9):e033474. doi: 10.1161/JAHA.123.033474. Epub 2024 May 3. J Am Heart Assoc. 2024. PMID: 38700020 Free PMC article.
-
Cardiovascular and Pulmonary Responses to Acute Use of Electronic Nicotine Delivery Systems and Combustible Cigarettes in Long-Term Users.Chest. 2023 Sep;164(3):757-769. doi: 10.1016/j.chest.2023.03.047. Epub 2023 Apr 10. Chest. 2023. PMID: 37044158 Free PMC article.
-
DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.Circ Cardiovasc Genet. 2015 Oct;8(5):707-16. doi: 10.1161/CIRCGENETICS.115.001097. Epub 2015 Aug 25. Circ Cardiovasc Genet. 2015. PMID: 26307030 Free PMC article.
-
Reproducibility of carotid ultrasound measurements in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) at baseline.Braz J Med Biol Res. 2019;52(8):e8711. doi: 10.1590/1414-431X20198711. Epub 2019 Aug 5. Braz J Med Biol Res. 2019. PMID: 31389494 Free PMC article.
References
-
- Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the american society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21:93–111. quiz 189–190. - PubMed
-
- Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115:459–467. - PubMed
-
- Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-analysis. Jama. 2012;308:796–803. - PubMed
-
- Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intima-media thickness and total plaque area: A 13-year follow-up study: The Tromsø study. Stroke. 2012;43:1818–1823. - PubMed
Publication types
MeSH terms
Grants and funding
- T32 HL007936/HL/NHLBI NIH HHS/United States
- HC95159-HC95169/HC/NHLBI NIH HHS/United States
- HL07936/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01 HC095161/HC/NHLBI NIH HHS/United States
- P50 ES015915/ES/NIEHS NIH HHS/United States
- N01 HC095165/HC/NHLBI NIH HHS/United States
- ES015915/ES/NIEHS NIH HHS/United States
- K23 HL094760/HL/NHLBI NIH HHS/United States
- N01 HC095162/HC/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- S10 RR021086/RR/NCRR NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N01 HC095164/HC/NHLBI NIH HHS/United States
- N01 HC095166/HC/NHLBI NIH HHS/United States
- N01 HC095160/HC/NHLBI NIH HHS/United States
- RR025005/RR/NCRR NIH HHS/United States
- RR024156/RR/NCRR NIH HHS/United States
- HL 094760/HL/NHLBI NIH HHS/United States
- N01 HC095163/HC/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- T32 HL07936/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical